CELU
Celularity Inc
NASDAQ: CELU · HEALTHCARE · BIOTECHNOLOGY
$0.93
-2.68% today
Updated 2026-04-30
Market cap
$32.01M
P/E ratio
—
P/S ratio
0.79x
EPS (TTM)
$-3.33
Dividend yield
—
52W range
$1 – $4
Volume
0.2M
Celularity Inc (CELU) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-543.00 | $-1.10M | $-63.19M | $-110.10M | $-137.88M | $-38.69M | $-6.40M |
| Capital expenditures | $1.92M | $3.00 | $27.83M | $6.20M | $5.24M | $4.05M | $161000.00 |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | $4.50M | $3.67M | $4.37M | $40.01M | $15.86M | $15.02M | $11.57M |
| Free cash flow | $-1.92M | $-1.10M | $-91.03M | $-116.30M | $-143.11M | $-42.73M | $-6.56M |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | $39.07M | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | $892300.00 | $-602311.00 | — | — | — | — |